TPO accused of cherry-picking comparables
The Mumbai Income Tax Tribunal (ITAT) has sent back the file of Teva India, dealing with pharmaceuticals, to the transfer pricing officer (TPO) to reassess whether Vimta Labs, a contract research and testing organisation with abnormally high profit, is comparable to a contract R&D provider.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
